NEW DELHI – Pharmaceutical manufacturers and policy makers in India are growing increasingly concerned about the country's dependence on China as the single source for bulk drugs and intermediary products that are necessary to the production of a wide range of products. Read More

HONG KONG – As part of an ongoing process of strengthening the country's drug regulatory structure, the CFDA is looking to end region-to-region variation in the strength of clinical trial oversight. Read More

HONG KONG — Chinese researchers have discovered that an antifungal drug can efficiently block bacterial virulence due to Staphylococcus aureus infections, including those caused by methicillin-resistant Staphylococcus aureus (MRSA) strains of the bacterium, in mouse models of infection, they reported in the Jan. 18, 2015, edition of Nature Chemical Biology. Read More

HONG KONG – Japanese pharma major Daiichi Sankyo Co. Ltd., looking to enter the biosimilar game, reported positive results from a co-developed drug that could become the country's first biosimilar etanercept. Read More

SAN FRANCISCO – The J.P. Morgan Healthcare Conference might be reluctant to change, dedicated to the same (crowded) hotel venue for the past 34 years, but it is open to a rapidly growing group of attendees, with last week's meeting inviting a substantial number of people from China. Read More

HONG KONG – South Korea's Samsung Bioepis Co. Ltd. got the first EU approval for biosimilar etanercept, a win that opens up the European market for a company that is working to become a global top-tier biosimilar maker. Read More